Shanghai Liantang Pharmaceutical

Shanghai Liantang Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drug products and active pharmaceutical ingredients (APIs). Founded in 1994 and headquartered in the Qingpu District of Shanghai, the company focuses on chronic disease management, particularly in the fields of cardiovascular health, metabolic disorders, and gastroenterology. Its commercial portfolio includes essential generic medications such as metformin, gliclazide, and amlodipine. The company operates GMP-certified manufacturing facilities capable of producing various oral solid dosage forms, including tablets and capsules. Shanghai Liantang Pharmaceutical serves both the domestic Chinese healthcare market and international partners through its API and finished formulation divisions.